Generic Pharmaceuticals Businesses Seeking Loan

Specializes in marketing a broad portfolio of 18 generic pharmaceutical products, encompassing antibiotics, antacids, muscle relaxants, multivitamins, analgesics, and antipyretics, ensuring a comprehensive healthcare solution. - Operates as a marketing company with third-party manufacturing arrangements, allowing for a focus on branding and distribution strategies within the pharmaceutical industry. - Strategically based in Kolhapur, the company leverages local and regional distribution to maintain robust relationships with 6 dedicated distributors and a network of over 600 doctors. - Utilizes the promoter's 16 years of extensive experience in the pharma sector to navigate regulatory landscapes and optimize marketing efficacy. - Conducts business under a registered and trademarked pharmaceutical brand, enhancing brand recognition and customer loyalty in the healthcare market. - The company's lean operational model with 3 employees highlights efficiency in pharma marketing, ensuring focused client interactions and streamlined customer service. - Holds a drug license, ensuring compliance with pharmaceutical regulations and maintaining high-quality standards for its health products.

Our company outsources the manufacturing of generic pharmaceuticals which are then supplied to our customers under our trademarked brand names. - The manufacturing is outsourced from 10 manufacturers in Haridwar, Chandigarh, and Himachal Pradesh. They package the final products under our brand names and send them to us. All the products are proprietary and exclusive to our company. - Currently, we have about 8 different general medicines under our company. The intellectual property and patents on the chemical formulations of these medicines are owned by us. We used a third-party pharmaceutical company for helping us develop the drug. All the products are approved by CDSCO. - The promoters have a long-standing experience in the pharmaceutical industry which led them to bootstrap their own company. - Each of the medicine is sold under a different name. All 8 names have been trademarked and we possess their ownership. There is an equal production and demand of all the products. There are 5 to 7 more drugs under development and will be launched in the upcoming months. - Our products are sold to about 100 distributors who further sell them to pharmacy stores across Uttarakhand, Madhya Pradesh, and Delhi. This is the only source of revenue for our company. We have not begun any direct-to-consumer sales yet. We receive anywhere between 60 to 70 purchase orders of varied sizes every month. - The business is extremely valuable due to our fleet of patented drugs, more drugs in the pipeline, and constant growth in the business. The valuation is based on our own estimate.

Our company outsources the manufacturing of generic pharmaceuticals which are then supplied to our customers under our trademarked brand names. - The manufacturing is outsourced from 10 manufacturers in Haridwar, Chandigarh, and Himachal Pradesh. They package the final products under our brand names and send them to us. All the products are proprietary and exclusive to our company. - Currently, we have about 8 different general medicines under our company. The intellectual property and patents on the chemical formulations of these medicines are owned by us. We used a third-party pharmaceutical company for helping us develop the drug. All the products are approved by CDSCO. - The promoters have a long-standing experience in the pharmaceutical industry which led them to bootstrap their own company. - Each of the medicine is sold under a different name. All 8 names have been trademarked and we possess their ownership. There is an equal production and demand of all the products. There are 5 to 7 more drugs under development and will be launched in the upcoming months. - Our products are sold to about 100 distributors who further sell them to pharmacy stores across Uttarakhand, Madhya Pradesh, and Delhi. This is the only source of revenue for our company. We have not begun any direct-to-consumer sales yet. We receive anywhere between 60 to 70 purchase orders of varied sizes every month. - The business is extremely valuable due to our fleet of patented drugs, more drugs in the pipeline, and constant growth in the business. The valuation is based on our own estimate.

The business has developed 43 medicines under its own brand. We hold patents on 20 medicines and have a patent pending on others. The patents have been approved by IndiaFilings in Chennai. - We hold exclusive rights to manufacture & supply of these medicines. - We outsource the manufacturing of these drugs with over 20 manufacturers in Rajasthan who charge between 20 to 30 percent of MRSP of each drug. These numbers vary with different units of volume. These contracts have no expiration. - The business supplies these drugs to various hospitals in Rajasthan along with other B2B channels. No revenue is incurred via retail or B2C. - We sell our products at 90% of its MSRP and is fixed for all its products. The profit margin for all buyers remains fixed at 10%. - Our business follows WHO GMP (Good Manufacturing Practices) for creating its drugs along with several quality checks & health assessments. Pharma manufacturing licenses are also in possession of the business. - The business outsources its logistics for which the cost is borne by the buyers. - We commenced operations from November 2020. Prior to that we operated under a different brand name.